The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker

Atrial fibrillation (AF) is a major risk factor for stroke. We aim to characterize AF patients and the effects of apixaban therapy in terms of clot microstructure using gel point analysis, a novel biomarker. Seventy‐eight patients were included in the study, 50 Stroke with AF (AF‐S), and 28 AF witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrence, Matthew J., Evans, Vanessa, Whitley, Janet, Pillai, Suresh, Williams, Phylip R., Coulson, James, Krishnan, Manju, Slade, Peter, Power, Kieron, Morris, Roger H.K., Evans, Phillip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956932/
https://www.ncbi.nlm.nih.gov/pubmed/35338612
http://dx.doi.org/10.1002/prp2.937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956932/
https://www.ncbi.nlm.nih.gov/pubmed/35338612
http://dx.doi.org/10.1002/prp2.937

Ejemplares similares